Literature DB >> 6415245

Effect of mannitol and furosemide on blood-brain osmotic gradient and intracranial pressure.

M Pollay, C Fullenwider, P A Roberts, F A Stevens.   

Abstract

The effect of mannitol (1.0 gm/kg) and furosemide (0.7 mg/kg), alone and in combination, on the blood-brain extracellular fluid and cerebrospinal fluid (CSF) osmotic gradient, elevated intracranial pressure (ICP), CSF and serum osmolality, and urine output was studied in 26 mongrel dogs. Mannitol and furosemide, when used together, produced a greater (62.4% versus 56.6%) and more sustained (5 hours versus 2 hours) fall in ICP than mannitol alone. This correlated with a prolongation of the reversal of the blood-brain osmotic gradient (-3.4 to + 38.5 mOsm/kg) and a rate of urine formation 15 times control values. There was a transient but not significant fall in serum Na+ with the combined treatment, but the arterial pressure did not vary from pretreatment levels. The results from this present study suggest that the distal loop diuretics in a dose of less than 1.0 mg/kg act synergistically with mannitol by causing preferential excretion of water over solute in the renal distal tubule, and thereby sustaining the osmotic gradient initially established by the mannitol infusion. It is possible, but unlikely in the doses used, that the additive effect of furosemide on reducing ICP in the presence of mannitol is due to interference with CSF formation or Na+ and H2O movement across the blood-brain barrier.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6415245     DOI: 10.3171/jns.1983.59.6.0945

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  13 in total

Review 1.  Neurological intensive care in children.

Authors:  J Pfenninger
Journal:  Intensive Care Med       Date:  1993       Impact factor: 17.440

Review 2.  Japanese viral encephalitis.

Authors:  S V Tiroumourougane; P Raghava; S Srinivasan
Journal:  Postgrad Med J       Date:  2002-04       Impact factor: 2.401

3.  Idiopathic intracranial hypertension.

Authors:  Melissa W Ko
Journal:  Curr Treat Options Neurol       Date:  2011-02       Impact factor: 3.598

4.  Idiopathic intracranial hypertension.

Authors:  Michael Wall
Journal:  Neurol Clin       Date:  2010-08       Impact factor: 3.806

Review 5.  The impact of technical adjuncts in the surgical management of cerebral hemispheric low-grade gliomas of childhood.

Authors:  M S Berger
Journal:  J Neurooncol       Date:  1996 May-Jun       Impact factor: 4.130

Review 6.  Contemporary management of traumatic intracranial hypertension: is there a role for therapeutic hypothermia?

Authors:  Matthew Schreckinger; Donald W Marion
Journal:  Neurocrit Care       Date:  2009-12       Impact factor: 3.210

7.  Use of mannitol during neurosurgery: interpatient variability in the plasma and CSF levels.

Authors:  P Anderson; L Boréus; E Gordon; M Lagerkranser; A Rudehill; C Lindquist; G Ohman
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

Review 8.  Idiopathic intracranial hypertension (pseudotumor cerebri).

Authors:  Michael Wall
Journal:  Curr Neurol Neurosci Rep       Date:  2008-03       Impact factor: 5.081

9.  Interstitial fluid pressure in intracranial tumours in patients and in rodents.

Authors:  Y Boucher; H Salehi; B Witwer; G R Harsh; R K Jain
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

10.  Iatrogenic cerebral arterial gas embolism from flushing of the arterial line in two calves.

Authors:  Daniela Casoni; Alessandro Mirra; Christine Goepfert; Ilaria Petruccione; Claudia Spadavecchia
Journal:  Acta Vet Scand       Date:  2018-09-06       Impact factor: 1.695

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.